HomeInsights52 Week Low Stocks

Welcure Drugs & Pharmaceuticals Ltd 52 Week Low

Welcure Drugs & Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

22.8 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 12, 2024

Image

Welcure Drugs & Pharmaceuticals Ltd

NSE: WELCUREDRUGS

YEARLOW

₹ 3.76

Last updated on: Dec 11, 2024

Key Highlights

  • The 52 Week Low of Welcure Drugs & Pharmaceuticals Ltd is ₹ 3.76 as of 11 Dec 24 .

Company Fundamentals for Welcure Drugs & Pharmaceuticals Ltd

No data available

Market Price of Welcure Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Welcure Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 20249.75
10 Dec 20248.87
09 Dec 20248.07
02 Dec 20248.07
25 Nov 20248.07
18 Nov 20248.07
11 Nov 20248.07
04 Nov 20247.69
28 Oct 20247.69
21 Oct 20247.69

Asset Value vs Market Value of Welcure Drugs & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Welcure Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Welcure Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Welcure Drugs & Pharmaceuticals Ltd News Hub

News

Welcure Drugs & Pharmaceuticals revises board meeting date

Welcure Drugs & Pharmaceuticals has revised the meeting of the Board of Directors which wa...

Read more

14 Nov 2024 10:33

News

Welcure Drugs & Pharmaceuticals to hold board meeting

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

08 Nov 2024 17:01

News

Welcure Drugs & Pharmaceuticals to hold board meeting

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

17 Oct 2024 17:08

News

Welcure Drugs & Pharmaceuticals to convene AGM

Welcure Drugs & Pharmaceuticals announced that the Annual General Meeting (AGM) of the com...

Read more

11 Sep 2024 10:36

News

Welcure Drugs & Pharmaceuticals to conduct AGM

Welcure Drugs & Pharmaceuticals announced that the Annual General Meeting (AGM) of the com...

Read more

11 Sep 2024 10:29

News

Welcure Drugs & Pharmaceuticals to hold board meeting

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

30 Aug 2024 11:18

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Welcure Drugs & Pharmaceuticals Ltd

Why is it important to track the 52-week low of Welcure Drugs & Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Welcure Drugs & Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Welcure Drugs & Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Welcure Drugs & Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Welcure Drugs & Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Welcure Drugs & Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Welcure Drugs & Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Welcure Drugs & Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Welcure Drugs & Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Welcure Drugs & Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Welcure Drugs & Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Welcure Drugs & Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Welcure Drugs & Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions